Proposal for new USP Chapter <317> ICP OES Testing for Sodium Hydroxide and Potassium Hydroxide Published for Comments

Recommendation
18/19 February 2025
All you need to know
In the Pharmacopeial Forum, PF 50(3), a proposal for a new General Chapter <317> ICP OES Testing for Sodium Hydroxide and Potassium Hydroxide was published. The text was developed by the Excipients Test Methods Expert Committee (ETM EC). Commenting is open until 31 July 2024.
The briefing notes state that "the proposal contains ICP-OES methods for the determination of Content of Sodium in Sodium Hydroxide and Content of Potassium in Potassium Hydroxide. The methods are based on the validated ICP-OES methods of analysis. Similarly, for the tests related to the estimation of potassium as an impurity in Sodium Hydroxide and sodium as an impurity in Potassium Hydroxide, an ICP-OES-based method is being proposed."
The Chapter is applicable to the analysis of sodium hydroxide and potassium hydroxide only. In the briefing notes, it is pointed out that the chapter does not cover analysis of other related excipients. Furthermore, "the methods in this general chapter are nonmandatory and are not part of Sodium Hydroxide and Potassium Hydroxide monograph specification in the absence of a reference in the General Notices, a monograph, or another applicable general chapter numbered below 1000."
The proposal is structured as follows:
- Methods
- Content of Sodium in Sodium Hydroxide
- Content of Potassium in Potassium Hydroxide
- Potassium as an Impurity in Sodium Hydroxide - Additional Requirements
- USP Reference Standards <11>
The full text and further information are available via the USP website access point.
Related GMP News
12.02.2025USP Announces Corrections to General Chapter <1132.1> on Residual Host Cell Protein Measurement
12.02.2025FDA Warning Letter: Focus on Quality Control of APIs and Excipients
29.01.2025Revision of USP <1032> Design and Development of Biological Assays
23.01.2025English Translation of Supplement II to the Japanese Pharmacopoeia (JP18) Published
23.01.2025How to keep Analytical Systems Current and Compliant
23.01.2025FDA 483s due to Deficiencies in the Stability Program: Evaluation of Fiscal Year 2024